Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Eli Lilly’s Lackluster Pipeline + Premium Valuation = Goldman Sachs Downgrade
Eli Lilly’s Lackluster Pipeline + Premium Valuation = Goldman Sachs Downgrade
Eli Lilly’s Lackluster Pipeline + Premium Valuation = Goldman Sachs Downgrade
Submitted by
admin
on November 11, 2013 - 2:19pm
Source:
Barron's
News Tags:
Eli Lilly
Headline:
Eli Lilly’s Lackluster Pipeline + Premium Valuation = Goldman Sachs Downgrade
Do Not Allow Advertisers to Use My Personal information
